HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

Objective. We assess the behavior of serum concentrations of HE4 marker in female carriers of BRCA1 and assess the diagnostic usefulness of HE4 in ovarian and endometrial cancer. Methods. A total of 619 women with BRCA1 gene mutation, ovarian, endometrial, metastatic, other gynecological cancers, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Chudecka-Głaz, Anita, Cymbaluk-Płoska, Aneta, Strojna, Aleksandra, Menkiszak, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274692/
https://www.ncbi.nlm.nih.gov/pubmed/28182133
http://dx.doi.org/10.1155/2017/9792756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274692/
https://www.ncbi.nlm.nih.gov/pubmed/28182133
http://dx.doi.org/10.1155/2017/9792756

Ejemplares similares